doxorubicin

A promising new mesothelioma treatment targeting only malignant cells showed favorable results in a preliminary study on laboratory mice, report researchers at the University of Vermont Medical College. If the results can be replicated in humans, this could be a significant step to a breakthrough therapy for this currently incurable asbestos-caused cancer. “Effective treatment of malignant mesothelioma remains an unmet clinical need,”[1] the study researchers state in their paper published this week in the online journal BMC-Cancer. With grant funding from the Mesothelioma Applied Research … [Read more...]